Flynn Karen 4
4 · Catalent, Inc. · Filed Jul 28, 2021
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
Flynn Karen
Pres. Biologics & CCO
Transactions
- Award
Common Stock
2021-07-26+1,151→ 35,695 total - Award
Options to purchase Common Stock
2021-07-26+5,953→ 5,953 totalExercise: $113.00Exp: 2031-07-26→ Common Stock (5,953 underlying)
Footnotes (4)
- [F1]Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
- [F2]Includes restricted stock units.
- [F3]Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
- [F4]The options vest and become exercisable in four equal annual installments beginning on July 26, 2022.